IMC vs MVP

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

IMC

IMMURON FPO [IMC]

51MEDIUM

MVP

MEDICALDEV FPO [MVP]

51MEDIUM

Score Breakdown

IMC MVP
Technical
69
72
Catalyst
50
50
Sentiment
50
50
Fundamental
64
88
Momentum
39
41
Risk Gate
45
50

Key Metrics

IMC Metric MVP
$9.5MMarket Cap$44.5M
245KAvg Volume (20d)102K
N/AShort InterestN/A
$0.09852-Week High$0.765
$0.02752-Week Low$0.380
+3.4%Daily Change+2.6%
$0.030Entry Price$0.395
-39.7%ROE-0.8%
-62.1%Profit Margin-1.1%

Active Signals

IMC Signals

MACD just crossed bullish — momentum is shifting to the upside
Above-average volume (1.9x) on a green day — buyers stepping up
On a tear — up 11.1% over the last 5 days
Beating the Small Ords index — relative strength of 1.16, so it's outpacing the pack
Volatility is expanding fast — choppy price action, so buckle up
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (9 quarters)
Low P/S ratio (1.3x)

MVP Signals

RSI drifting toward oversold territory — worth watching
MACD just crossed bullish — momentum is shifting to the upside
Volume surging at 2.1x normal while price climbs — real buying conviction behind this move
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
4C filed 2026-01-29
Low P/S ratio (1.1x)

Ask Scout AI to compare IMC and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IMC Full Analysis → MVP Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).